Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure

Archive ouverte

Desbats, Maria | Vetro, Annalisa | Limongelli, Ivan | Lunardi, Giada | Casarin, Alberto | Doimo, Mara | Spinazzi, Marco | Angelini, Corrado | Cenacchi, Giovanna | Burlina, Alberto | Rodriguez Hernandez, Maria Angeles | Chiandetti, Lino | Clementi, Maurizio | Trevisson, Eva | Navas, Placido | Zuffardi, Orsetta | Salviati, Leonardo

Edité par CCSD -

International audience. Coenzyme Q10 deficiency is a clinically and genetically heterogeneous disorder, with manifestations that may range from fatal neonatal multisystem failure, to adult-onset encephalopathy. We report a patient who presented at birth with severe lactic acidosis, proteinuria, dicarboxylic aciduria, and hepatic insufficiency. She also had dilation of left ventricle on echocardiography. Her neurological condition rapidly worsened and despite aggressive care she died at 23 h of life. Muscle histology displayed lipid accumulation. Electron microscopy showed markedly swollen mitochondria with fragmented cristae. Respiratory-chain enzymatic assays showed a reduction of combined activities of complex I+III and II+III with normal activities of isolated complexes. The defect was confirmed in fibroblasts, where it could be rescued by supplementing the culture medium with 10 μM coenzyme Q10. Coenzyme Q10 levels were reduced (28% of controls) in these cells. We performed exome sequencing and focused the analysis on genes involved in coenzyme Q10 biosynthesis. The patient harbored a homozygous c.545T>G, p.(Met182Arg) alteration in COQ2, which was validated by functional complementation in yeast. In this case the biochemical and morphological features were essential to direct the genetic diagnosis. The parents had another pregnancy after the biochemical diagnosis was established, but before the identification of the genetic defect. Because of the potentially high recurrence risk, and given the importance of early CoQ10 supplementation, we decided to treat with CoQ10 the newborn child pending the results of the biochemical assays. Clinicians should consider a similar management in siblings of patients with CoQ10 deficiency without a genetic diagnosis.

Consulter en ligne

Suggestions

Du même auteur

Haploinsufficiency of COQ4 causes coenzyme Q10 deficiency.

Archive ouverte | Salviati, Leonardo | CCSD

International audience. BACKGROUND: COQ4 encodes a protein that organises the multienzyme complex for the synthesis of coenzyme Q(10) (CoQ(10)). A 3.9 Mb deletion of chromosome 9q34.13 was identified in a 3-year-old...

Copper and bezafibrate cooperate to rescue cytochrome c oxidase deficiency in cells of patients with SCO2 mutations.

Archive ouverte | Casarin, Alberto | CCSD

International audience. BACKGROUND: Mutations in SCO2 cause cytochrome c oxidase deficiency (COX) and a fatal infantile cardioencephalomyopathy. SCO2 encodes a protein involved in COX copper metabolism; supplementat...

Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency.

Archive ouverte | Doimo, Mara | CCSD

International audience. : Human COQ6 encodes a monooxygenase which is responsible for the C5-hydroxylation of the quinone ring of coenzyme Q (CoQ). Mutations in COQ6 cause primary CoQ deficiency, a condition respons...

Chargement des enrichissements...